DYN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Dyne Therapeutics Inc (DYN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive momentum, has weak financial performance, and no significant trading signals or recent positive news catalysts. While analysts are generally optimistic with high price targets, the current technical and financial indicators suggest waiting for a better entry point.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is at 26.26, which is neutral but close to oversold territory. Moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 16.159), with resistance levels significantly higher (R1: 18.901). Overall, the technical indicators suggest a weak trend.
The stock has been upgraded by multiple firms recently.
and a weak short-term trend, with a forecasted decline of -5.89% in the next month. Financial performance remains poor, with negative net income and declining EPS.
In Q3 2025, revenue remained at $0 with no growth. Net income improved slightly YoY but is still deeply negative at -$108.04M. EPS dropped by -20.83% YoY to -0.76, indicating worsening profitability. Gross margin remains at 0%. Overall, the company's financials are weak.
Analysts are generally bullish, with multiple upgrades and price targets ranging from $23 to $60. Positive sentiment is driven by promising data for DYN-251 and potential accelerated approvals. However, these catalysts are long-term and contingent on future developments.
